Lan Ma
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- Mitochondrial Function and Pathology 3
- Metabolomics and Mass Spectrometry Studies 3
- Genetics 11
- High Altitude and Hypoxia 10
- Co-authors
- Imran Ahmad (1 shared paper)Sydney O. Ugwu (1 shared paper)Gopal Anyarambhatla (1 shared paper)Ri‐Li Ge (10 shared papers)Qin Ga (6 shared papers)Dianxiang Lu (4 shared papers)Zhenzhong Bai (3 shared papers)Ri‐Li Ge (8 shared papers)
- Journals
- Gene (3 papers)High Altitude Medicine & Biology (2 papers)Parasites & Vectors (2 papers)Biochemical and Biophysical Research Communications (2 papers)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Lan Ma
36 papers receiving 872 citations
Peers
Comparison fields: 5 of 117
- Biomaterials 207
- Pharmaceutical Science 64
- Immunology 115
- Infectious Diseases 99
- Molecular Biology 331
Countries citing papers authored by Lan Ma
This map shows the geographic impact of Lan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Ma more than expected).
Fields of papers citing papers by Lan Ma
This network shows the impact of papers produced by Lan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Ma. The network helps show where Lan Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Lan Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 271 | |
| 2 | 2019 | 67 | |
| 3 | 2019 | 65 | |
| 4 | 2019 | 48 | |
| 5 | 2019 | 40 | |
| 6 | 2003 | 38 | |
| 7 | 2018 | 36 | |
| 8 | 2017 | 25 | |
| 9 | 2015 | 22 | |
| 10 | 2015 | 21 | |
| 11 | 2017 | 18 | |
| 12 | 2013 | 17 | |
| 13 | 2014 | 16 | |
| 14 | The combination of crocin with cisplatin suppresses growth of gastric carcinoma cell line BGC-823 and promotes cell apoptosis. | 2017 | 16 |
| 15 | 2017 | 15 | |
| 16 | 2021 | 15 | |
| 17 | 2015 | 14 | |
| 18 | 2013 | 14 | |
| 19 | 2017 | 14 | |
| 20 | 2008 | 13 |
About Lan Ma
Lan Ma is a scholar working on Molecular Biology, Genetics, Immunology, Physiology and Pathology and Forensic Medicine, having authored 37 papers that have together received 887 indexed citations. Recurring topics across this work include High Altitude and Hypoxia (10 papers), Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers), Neuroscience of respiration and sleep (4 papers), Mitochondrial Function and Pathology (3 papers), Parasitic infections in humans and animals (3 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). The work is most often cited by research in Biomaterials (207 citations), Pharmaceutical Science (64 citations), Immunology (115 citations), Infectious Diseases (99 citations) and Molecular Biology (331 citations). Lan Ma has collaborated with scholars based in China and United States. Frequent co-authors include Imran Ahmad, Sydney O. Ugwu, Gopal Anyarambhatla, Ri‐Li Ge, Qin Ga, Dianxiang Lu, Zhenzhong Bai, Ri‐Li Ge, Zhanqiang Li and Yingzhong Yang. Their work appears in journals such as Gene, High Altitude Medicine & Biology, Parasites & Vectors, Biochemical and Biophysical Research Communications and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.